{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T21:25:51Z","timestamp":1748985951783},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T00:00:00Z","timestamp":1406160000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0103572","type":"journal-article","created":{"date-parts":[[2014,7,25]],"date-time":"2014-07-25T06:59:19Z","timestamp":1406271559000},"page":"e103572","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Is the Risk of Motor Neuron Disease Increased or Decreased after Cancer? An Australian Case-Control Study"],"prefix":"10.1371","volume":"9","author":[{"given":"Alex","family":"Stoyanov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Pamphlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,7,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0098-2997(00)00007-8","article-title":"The molecular biology of cancer","volume":"21","author":"JS Bertram","year":"2000","journal-title":"Mol Aspects Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jgo.2011.11.007","article-title":"Understanding the link between cancer and neurodegeneration","volume":"3","author":"JA Driver","year":"2012","journal-title":"J Geriatr Onc"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e1001257","DOI":"10.1371\/journal.pgen.1001257","article-title":"Cancer and neurodegeneration: between the devil and the deep blue sea","volume":"6","author":"H Plun-Favreau","year":"2010","journal-title":"PLoS Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S1470-2045(11)70041-9","article-title":"No paradox, no progress: inverse cancer comorbidity in people with other complex diseases","volume":"12","author":"R Tabares-Seisdedos","year":"2011","journal-title":"Lancet Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e1442","DOI":"10.1136\/bmj.e1442","article-title":"Inverse association between cancer and Alzheimer&apos;s disease: results from the Framingham Heart Study","volume":"344","author":"JA Driver","year":"2012","journal-title":"BMJ"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e1662","DOI":"10.1136\/bmj.e1662","article-title":"A reduced risk of Alzheimer&apos;s disease in those who survive cancer","volume":"344","author":"M Ganguli","year":"2012","journal-title":"BMJ"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1212\/WNL.0b013e3181c91873","article-title":"Cancer linked to Alzheimer disease but not vascular dementia","volume":"74","author":"CM Roe","year":"2010","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000356498","article-title":"Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies","volume":"83","author":"F Catala-Lopez","year":"2014","journal-title":"Psychother Psychosom"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10552-009-9497-6","article-title":"Parkinson&apos;s disease and cancer risk: a systematic review and meta-analysis","volume":"21","author":"A Bajaj","year":"2010","journal-title":"Cancer Causes Control"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10552-007-9005-9","article-title":"Prospective case-control study of nonfatal cancer preceding the diagnosis of Parkinson&apos;s disease","volume":"18","author":"JA Driver","year":"2007","journal-title":"Cancer Causes Control"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000331489","article-title":"Analysis of Parkinson&apos;s disease and subsequent cancer risk in Taiwan: a nationwide population-based cohort study","volume":"37","author":"LM Sun","year":"2011","journal-title":"Neuroepidemiology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1358\/dot.2011.47.3.1519657","article-title":"Cancer and Parkinson&apos;s disease: the odd couple","volume":"47","author":"X Gao","year":"2011","journal-title":"Drugs Today"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/ijc.27443","article-title":"Malignant melanoma, breast cancer and other cancers in patients with Parkinson&apos;s disease","volume":"131","author":"K Rugbjerg","year":"2012","journal-title":"Int J Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/mds.23246","article-title":"Comorbid cancer in Parkinson&apos;s disease","volume":"25","author":"RY Lo","year":"2010","journal-title":"Mov Disord"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00018-007-7270-0","article-title":"Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer&apos;s disease","volume":"65","author":"K Takahashi","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tibs.2004.02.002","article-title":"Pinning down cell signaling, cancer and Alzheimer&apos;s disease","volume":"29","author":"KP Lu","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/em.20575","article-title":"Mitochondrial dysfunction in neurodegenerative diseases and cancer","volume":"51","author":"MB de Moura","year":"2010","journal-title":"Environ Mol Mutagen"},{"key":"ref18","first-page":"71","article-title":"Oxygen sensing: a common crossroad in cancer and neurodegeneration","volume":"345","author":"A Quaegebeur","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"MC Kiernan","year":"2011","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/brain\/88.3.479","article-title":"Motor neurone disease as a manifestation of neoplasm (with a note on the course of classical motor neurone disease)","volume":"88","author":"L Brain","year":"1965","journal-title":"Brain"},{"key":"ref21","first-page":"119","article-title":"Remote effects of focal cancer on the neuromuscular system","volume":"15","author":"WK Engel","year":"1976","journal-title":"Adv Neurol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ana.410410608","article-title":"Motor neuron syndromes in cancer patients","volume":"41","author":"PA Forsyth","year":"1997","journal-title":"Ann Neurol"},{"key":"ref23","first-page":"267","article-title":"Cancer and disorders of motor neurons","volume":"36","author":"KD Barron","year":"1982","journal-title":"Adv Neurol"},{"key":"ref24","first-page":"201","article-title":"Amyotrophic lateral sclerosis in cancer","volume":"19","author":"NK Vemireddi","year":"1978","journal-title":"J Miss State Med Assoc"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000087447","article-title":"Amyotrophic lateral sclerosis mortality in 1.9 million US cancer survivors","volume":"25","author":"DM Freedman","year":"2005","journal-title":"Neuroepidemiology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/jnnp.2009.175463","article-title":"Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson&apos;s disease: record linkage studies","volume":"81","author":"AF Fois","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10552-012-0089-5","article-title":"The association between cancer and amyotrophic lateral sclerosis","volume":"24","author":"DM Freedman","year":"2013","journal-title":"Cancer Causes Control"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3109\/21678421.2013.775309","article-title":"Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden","volume":"14","author":"F Fang","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref29","unstructured":"Freedman DM, Wu J, Daugherty SE, Kuncl RW, Enewold LR, <etal>et al<\/etal>.. (2014) The risk of amyotrophic lateral sclerosis after cancer in U.S. elderly adults: A population-based prospective study. Int J Cancer Epub date 2014\/02\/20 DOI 10.1002\/ijc.28795."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000336013","article-title":"Smoking is not a risk factor for sporadic amyotrophic lateral sclerosis in an Australian population","volume":"38","author":"R Pamphlett","year":"2012","journal-title":"Neuroepidemiology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.det.2012.04.001","article-title":"Update on the current state of melanoma incidence","volume":"30","author":"EG Little","year":"2012","journal-title":"Dermatol Clin"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"BR Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6339\/JDS.2008.06(4).395","article-title":"A solution to separation and multicollinearity in multiple logistic regression","volume":"6","author":"J Shen","year":"2008","journal-title":"J Data Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00423-006-0111-z","article-title":"Cigarette smoking: cancer risks, carcinogens, and mechanisms","volume":"391","author":"S Hecht","year":"2006","journal-title":"Langenbecks Arch Surg"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00265-010-1014-0","article-title":"Good practice in testing for an association in contingency tables","volume":"64","author":"G Ruxton","year":"2010","journal-title":"Behav Ecol Sociobiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10654-010-9437-5","article-title":"Curbing type I and type II errors","volume":"25","author":"KJ Rothman","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1212\/WNL.0b013e3181c1df48","article-title":"Smoking may be considered an established risk factor for sporadic ALS","volume":"73","author":"C Armon","year":"2009","journal-title":"Neurology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/archneurol.2010.367","article-title":"Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts","volume":"68","author":"H Wang","year":"2011","journal-title":"Arch Neurol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000097851","article-title":"Mortality due to amyotrophic lateral sclerosis and Parkinson&apos;s disease among melanoma patients","volume":"28","author":"PD Baade","year":"2007","journal-title":"Neuroepidemiology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000321930","article-title":"Can mortality data be used to estimate amyotrophic lateral sclerosis incidence?","volume":"36","author":"B Marin","year":"2011","journal-title":"Neuroepidemiology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1474-4422(05)70142-3","article-title":"Apoptosis in amyotrophic lateral sclerosis-what is the evidence?","volume":"4","author":"S Sathasivam","year":"2005","journal-title":"Lancet Neurol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1172\/JCI42986","article-title":"Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis","volume":"120","author":"NA Reyes","year":"2010","journal-title":"J Clin Invest"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2004.06.021","article-title":"Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria","volume":"43","author":"P Pasinelli","year":"2004","journal-title":"Neuron"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1006\/nbdi.2000.0314","article-title":"p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis","volume":"7","author":"LJ Martin","year":"2000","journal-title":"Neurobiol Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1046\/j.1365-2990.2000.026002150.x","article-title":"Motor neuronal death in sporadic amyotrophic lateral sclerosis (ALS) is not apoptotic. A comparative study of ALS and chronic aluminium chloride neurotoxicity in New Zealand white rabbits","volume":"26","author":"BP He","year":"2000","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref46","first-page":"75","article-title":"Does apoptosis occur in amyotrophic lateral sclerosis? TUNEL experience from human amyotrophic lateral sclerosis (ALS) tissues","volume":"43","author":"B Tomik","year":"2005","journal-title":"Folia Neuropathol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"8774","DOI":"10.1523\/JNEUROSCI.2315-06.2006","article-title":"Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS","volume":"26","author":"TW Gould","year":"2006","journal-title":"J Neurosci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1016\/j.bmc.2012.07.004","article-title":"Riluzole prodrugs for melanoma and ALS: design, synthesis, and in vitro metabolic profiling","volume":"20","author":"ME McDonnell","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/mds.22855","article-title":"Skin cancer and Parkinson&apos;s disease","volume":"25","author":"JJ Ferreira","year":"2010","journal-title":"Mov Disord"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1212\/WNL.0b013e31821e554e","article-title":"Meta-analysis of the relationship between Parkinson disease and melanoma","volume":"76","author":"R Liu","year":"2011","journal-title":"Neurology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e10481","DOI":"10.1371\/journal.pone.0010481","article-title":"Parkinson&apos;s disease-related protein, alpha-synuclein, in malignant melanoma","volume":"5","author":"Y Matsuo","year":"2010","journal-title":"PLoS One"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"e19622","DOI":"10.1371\/journal.pone.0019622","article-title":"alpha-Synuclein expression selectively affects tumorigenesis in mice modeling Parkinson&apos;s disease","volume":"6","author":"E Israeli","year":"2011","journal-title":"PLoS One"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/toxsci\/kft076","article-title":"Specific pesticide-dependent increases in alpha-synuclein levels in human neuroblastoma (SH-SY5Y) and melanoma (SK-MEL-2) cell lines","volume":"133","author":"A Chorfa","year":"2013","journal-title":"Toxicol Sci"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1038\/cddis.2009.4","article-title":"Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson&apos;s disease","volume":"1","author":"TA Yacoubian","year":"2010","journal-title":"Cell Death Dis"},{"key":"ref55","first-page":"259381","article-title":"alpha-Synuclein modification in an ALS animal model","volume":"2013","author":"EJ Yang","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00401-003-0790-2","article-title":"Alpha-synuclein in motor neuron disease: an immunohistologic study","volume":"107","author":"MJ Doherty","year":"2004","journal-title":"Acta Neuropathol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/pcan.2011.29","article-title":"The impact of PSA testing frequency on prostate cancer incidence and treatment in older men","volume":"14","author":"YH Shao","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0103572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T09:00:41Z","timestamp":1717146041000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0103572"}},"subtitle":[],"editor":[{"given":"Sreeram V.","family":"Ramagopalan","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,24]]},"references-count":57,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0103572","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,24]]}}}